|
市場調査レポート
商品コード
1701637
クエチアピン中間化学品の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2025年～2030年Quetiapine Intermediate Chemicals Market Size, Share & Trends Analysis Report By Product (1-[2-(2-Hydroxyethoxy)ethyl] Piperazine, Dibenzo[b,f][1,4]thiazepin 11 (10 H)-one), By End-use, By Region, And Segment Forecasts, 2025 - 2030 |
||||||
カスタマイズ可能
|
|||||||
価格
| クエチアピン中間化学品の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2025年～2030年 |
|
出版日: 2025年03月27日
発行: Grand View Research
ページ情報: 英文 80 Pages
納期: 2～10営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
クエチアピン中間化学品市場の成長と動向：
Grand View Research, Inc.の最新レポートによると、世界のクエチアピン中間化学品市場規模は2030年までに658億米ドルに達し、2025年から2030年までのCAGRは4.9%で成長すると予測されています。
主な促進要因は、精神疾患の世界の発生率の上昇、クエチアピン需要の増加、したがってその中間体の必要性です。特に新興市場におけるジェネリック・ケチアピン生産の費用対効果は、効率的な中間体合成の需要を直接後押ししています。また、新しい製剤や送達システムを含む医薬品の技術革新は、これらの化学的構成要素の安定供給を必要とします。
統合失調症や双極性障害などの精神疾患の世界の負担は、重要な促進要因です。認知度と診断の向上は、クエチアピンのような効果的な治療薬に対する需要の高まりに寄与しています。ストレスの多いライフスタイル、社会経済的要因、人口の高齢化はすべて、精神疾患の有病率上昇に寄与しています。
先発品であるクエチアピンの特許が切れたことで、ジェネリック医薬品メーカーに市場が開放されました。これにより競争が激化し、費用対効果の高い生産が重視されるようになり、手ごろな価格の中間化学薬品の需要に直接影響を与えています。製薬会社は、徐放性製剤や新しいデリバリーシステムなど、クエチアピンの新しい製剤を継続的に研究開発しています。このような研究開発活動には、高品質の中間体の安定供給が必要です。
精神疾患の有病率の増加は、クエチアピンに対する医薬品需要を直接的に促進するため、その中間体化学品の必要性を高めています。費用対効果の高いジェネリック医薬品製造の推進により、製薬会社はこれらの中間体を効率的に調達する必要に迫られています。新規のクエチアピン製剤やデリバリーシステムに焦点を当てた医薬品の研究開発努力は、これらの重要な化学構成要素の需要増加にさらに貢献しています。
アジア太平洋地域では、ヘルスケア支出の増加や精神疾患の有病率の上昇を背景に医薬品セクターが急成長を遂げており、クエチアピン需要を大幅に押し上げています。同地域では、安価な医薬品の提供を目的としたジェネリック医薬品製造に力を入れており、費用対効果の高いクエチアピン中間体の必要性が直接的に高まっています。さらに、APAC全域で現地での医薬品研究開発への投資が増加していることも、この重要な化学前駆体の需要拡大に寄与しています。
クエチアピン中間化学品市場レポートハイライト
- 最終用途に基づくと、医薬品セグメントが2024年に85.5%の最大収益シェアを占めると予想されます。統合失調症や双極性障害などの精神疾患の有病率が上昇していることが、クエチアピン需要の増加を促し、その結果、中間体化学品のニーズが高まっています。
- 製品別では、ジベンゾ[b,f][1,4]チアゼピン11（10 H）-オンセグメントが2024年に35.2%の最大の収益シェアを占め、予測期間中も業界を支配し続けると予想されます。これはクエチアピン合成の基本的な中間体であり、中核となる環構造を形成します。その生産効率はクエチアピンの生産量に直接影響するため、すべての上流中間体の需要に影響を与えます。
- 地域別では、アジア太平洋が2024年の売上高シェア50.7%を占めています。アジア太平洋地域の製薬業界は、ヘルスケア支出の増加や精神疾患の有病率の上昇を背景に急成長しており、クエチアピン中間体の需要を促進しています。
- 2024年12月、アミ・オーガニクス社は中国河北省の滄州工場で、多機能添加剤Nylostab S-EEDを製造するための第2製造ラインの建設を開始しました。この拡張は、北京天港補助有限公司との提携によるもので、中国のナイロン産業、特に繊維、自動車、包装分野での需要増に対応することを目的としています。
目次
第1章 調査手法と範囲
第2章 エグゼクティブサマリー
第3章 市場の変数、動向、範囲
- クエチアピン中間化学品の世界市場展望
- バリューチェーン分析
- 原材料の見通し
- 産業用冷凍機/製品展望
- 販売チャネル分析
- 価格動向分析
- 価格に影響を与える要因
- 規制の枠組み
- 標準とコンプライアンス
- 市場力学
- 市場促進要因分析
- 市場抑制要因分析
- 市場課題分析
- 市場機会分析
- ポーターのファイブフォース分析
- 供給企業の交渉力
- 買い手の交渉力
- 代替の脅威
- 新規参入業者の脅威
- 競争企業間の敵対関係
- PESTLE分析
- 政治的
- 経済
- 社会情勢
- 製品
- 環境
- 法律上
第4章 クエチアピン中間化学品市場：製品別推定・動向分析
- クエチアピン中間化学品市場：製品別変動分析、2024年および2030年
- 1-[2-（2-ヒドロキシエトキシ）エチル]ピペラジン
- ジベンゾ[b,f][1,4]チアゼピン11（10H）-オン
- その他の製品
第5章 クエチアピン中間化学品市場：最終用途別推定・動向分析
- クエチアピン中間化学品市場：最終用途別変動分析、2024年および2030年
- 医薬品
- その他の用途
第6章 クエチアピン中間化学品市場：地域別推定・動向分析
- 地域別分析、2024年と2030年
- 北米
- 製品別、2018年～2030年
- 最終用途別、2018年～2030年
- 米国
- カナダ
- メキシコ
- 欧州
- 製品別、2018年～2030年
- 最終用途別、2018年～2030年
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- アジア太平洋
- 製品別、2018年～2030年
- 最終用途別、2018年～2030年
- 中国
- インド
- 日本
- 韓国
- ラテンアメリカ
- 製品別、2018年～2030年
- 最終用途別、2018年～2030年
- ブラジル
- アルゼンチン
- 中東・アフリカ
- 製品別、2018年～2030年
- 最終用途別、2018年～2030年
- サウジアラビア
- 南アフリカ
第7章 競合情勢
- 主要市場参入企業の最近の動向
- 企業分類
- 企業ヒートマップ分析
- 2024年における企業市場ポジショニング分析
- 戦略マッピング
- 企業プロファイル/リスト
- Merck KGaA
- Shreeneel Chemicals
- Emeron Electric Co.
- Luye Pharma Group
- Argana Group
- IOL Chemicals &Pharmaceuticals Ltd
- AR Lifesciences
- ALLCHEM LIFESCIENCE PVT. LTD.
- AstraZeneca
- Shreeneel Chemicals
- Aether Industries
図表
List of Tables
- Table 1 Quetiapine Intermediate Chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD Million)
- Table 2 1-[2-(2-Hydroxyethoxy) ethyl] Piperazine quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD Million)
- Table 3 Dibenzo[b,f][1,4]thiazepin 11 (10 H)-one quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD Million)
- Table 4 Other product quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD Million)
- Table 5 Quetiapine intermediate chemicals market estimates & forecasts, by pharmaceuticals, 2018 - 2030 (Kilotons) (USD Million)
- Table 6 Quetiapine intermediate chemicals market estimates & forecasts, by other end uses, 2018 - 2030 (Kilotons) (USD Million)
- Table 7 Quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (USD Million)
- Table 8 Quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 9 Quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD Million)
- Table 10 Quetiapine Intermediate Chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 11 Quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD Million)
- Table 12 North America polyurethane Coatings market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
- Table 13 North America quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 14 North America quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD Million)
- Table 15 North America quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 16 North America quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD Million)
- Table 17 U.S. quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD Million)
- Table 18 U.S. quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 19 U.S. quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 20 U.S. quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 21 U.S. quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 22 Canada quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 23 Canada quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 24 Canada quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 25 Canada quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 26 Canada quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 27 Mexico quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 28 Mexico quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 29 Mexico quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 30 Mexico quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 31 Mexico quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 32 Europe quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 33 Europe quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 34 Europe quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 35 Europe quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 36 Europe quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 37 Germany quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 38 Germany quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 39 Germany quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 40 Germany quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 41 Germany quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 42 UK quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 43 UK quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 44 UK quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 45 UK quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 46 UK quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 47 France quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 48 France quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 49 France quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 50 France quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 51 France quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 52 Italy quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 53 Italy quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 54 Italy quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 55 Italy quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 56 Italy quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 57 Spain quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 58 Spain quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 59 Spain quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 60 Spain quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 61 Spain quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 62 Asia pacific quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 63 Asia pacific quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 64 Asia pacific quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 65 Asia pacific quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 66 Asia pacific quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 67 China quetiapine intermediate chemicals market estimates & forecast, 2018 - 2030 (Kilotons) (USD million)
- Table 68 China quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 69 China quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 70 China quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 71 China quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 72 India quetiapine intermediate chemicals market estimates & forecast, 2018 - 2030 (Kilotons) (USD million)
- Table 73 India quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 74 India quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 75 India quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 76 India quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 77 Japan quetiapine intermediate chemicals market estimates & forecast, 2018 - 2030 (Kilotons) (USD million)
- Table 78 Japan quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 79 Japan quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 80 Japan quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 81 Japan quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 82 South Korea quetiapine intermediate chemicals market estimates & forecast, 2018 - 2030 (Kilotons) (USD million)
- Table 83 South Korea quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 84 South Korea quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 85 South Korea quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 86 South Korea quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 87 Latin America quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 88 Latin America quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 89 Latin America quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 90 Latin America quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 91 Latin America quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 92 Brazil quetiapine intermediate chemicals market estimates & forecast, 2018 - 2030 (Kilotons) (USD million)
- Table 93 Brazil quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 94 Brazil quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 95 Brazil quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 96 Brazil quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 97 Argentina quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 98 Argentina quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 99 Argentina quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 100 Argentina quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 101 Argentina quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 102 Middle East & Africa quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 103 Middle East & Africa quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 104 Middle East & Africa quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 105 Middle East & Africa quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 106 Middle East & Africa quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 107 Saudi Arabia quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 108 Saudi Arabia quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 109 Saudi Arabia quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 110 Saudi Arabia quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 111 Saudi Arabia quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
- Table 112 South Africa quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
- Table 113 South Africa quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
- Table 114 South Africa quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
- Table 115 South Africa quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
- Table 116 South Africa quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
List of Figures
- Fig. 1 Market segmentation
- Fig. 2 Information procurement
- Fig. 3 Data analysis models
- Fig. 4 Market formulation and validation
- Fig. 5 Data validating & publishing
- Fig. 6 Market snapshot
- Fig. 7 Segmental outlook - End Use & Product
- Fig. 8 Competitive Outlook
- Fig. 9 Quetiapine Intermediate Chemicals market outlook, 2018 - 2030 (USD Million)
- Fig. 10 Value chain analysis
- Fig. 11 Market dynamics
- Fig. 12 Porter's Analysis
- Fig. 13 PESTEL Analysis
- Fig. 14 Quetiapine Intermediate Chemicals market, by product: Key takeaways
- Fig. 15 Quetiapine Intermediate Chemicals market, by product: Market share, 2024 & 2030
- Fig. 16 Quetiapine Intermediate Chemicals market, by end use: Key takeaways
- Fig. 17 Quetiapine Intermediate Chemicals market, by end use: Market share, 2024 & 2030
- Fig. 18 Quetiapine Intermediate Chemicals market: regional analysis, 2024
- Fig. 19 Quetiapine Intermediate Chemicals market, by region: Key takeaways
目次
Product Code: GVR-4-68040-543-8
Quetiapine Intermediate Chemicals Market Growth & Trends:
The global quetiapine intermediate chemicals market size is anticipated to reach USD 65.8 billion by 2030 and is anticipated to grow at a CAGR of 4.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary driver is the rising global incidence of mental health disorders, increasing quetiapine demand, and thus the need for its intermediates. The cost-effectiveness of generic quetiapine production, especially in emerging markets, directly fuels demand for efficient intermediate synthesis. Pharmaceutical innovation, including new formulations and delivery systems, also necessitates a steady supply of these chemical building blocks.
The global burden of mental illnesses, such as schizophrenia and bipolar disorder, is a significant driver. Increased awareness and diagnosis contribute to a higher demand for effective treatments like quetiapine. Stressful lifestyles, socioeconomic factors, and aging populations are all contributing to the rising prevalence of mental health disorders.
The expiration of patents on branded quetiapine has opened the market to generic drug manufacturers. This has led to increased competition and a focus on cost-effective production, which directly impacts the demand for affordable intermediate chemicals. Pharmaceutical companies are continuously researching and developing new formulations of quetiapine, such as extended-release versions and novel delivery systems. This research and development activity requires a consistent supply of high-quality intermediates.
The increased prevalence of mental health disorders directly drives pharmaceutical demand for quetiapine, thus escalating the need for its intermediate chemicals. The push for cost-effective generic drug manufacturing compels pharma companies to source these intermediates efficiently. Pharmaceutical R&D efforts focusing on novel quetiapine formulations and delivery systems further contribute to the rising demand for these crucial chemical building blocks.
The Asia-Pacific region is experiencing rapid growth in its pharmaceutical sector, driven by increasing healthcare expenditure and a rising prevalence of mental health disorders, significantly boosting quetiapine demand. The region's strong focus on generic drug manufacturing, aimed at providing affordable medications, directly amplifies the need for cost-effective quetiapine intermediates. Additionally, increasing investments in local pharmaceutical research and development across APAC further contribute to the growing demand for these crucial chemical precursors.
Quetiapine Intermediate Chemicals Market Report Highlights:
- Based on end use, the pharmaceuticals segment is expected to have the largest revenue share of 85.5% in 2024. The rising prevalence of mental health disorders, such as schizophrenia and bipolar disorder, is driving increased demand for quetiapine, consequently boosting the need for its intermediate chemicals.
- Based on product, the Dibenzo[b,f][1,4]thiazepin 11 (10 H)-one segment accounted for the largest revenue share of 35.2% in 2024 and is expected to continue to dominate the industry over the forecast period. It is a fundamental intermediate in quetiapine synthesis, forming the core ring structure. Its production efficiency directly impacts quetiapine output, thus influencing the demand for all upstream intermediates
- Based on region, Asia-Pacific dominated with a revenue share of 50.7% in 2024. The rapidly growing pharmaceutical industry in the Asia-Pacific region, driven by increasing healthcare expenditure and a rising prevalence of mental health disorders, fuels demand for quetiapine intermediates.
- In December 2024, Ami Organics Ltd. commenced construction of a second production line at its Cangzhou facility in Hebei Province, China, to manufacture the multifunctional additive Nylostab S-EED. This expansion, in partnership with Beijing Tiangang Auxiliary Co., Ltd., aims to meet the increasing demand from China's nylon industry, particularly in the textiles, automotive, and packaging sectors.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Information Analysis
- 1.3.2. Market Formulation & Data Visualization
- 1.3.3. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. Market Variables, Trends, and Scope
- 3.1. Global Quetiapine Intermediate Chemicals Market Outlook
- 3.2. Value Chain Analysis
- 3.2.1. Raw Material Outlook
- 3.2.2. Industrial Refrigeration/Product Outlook
- 3.2.3. Sales Channel Analysis
- 3.3. Price Trend Analysis
- 3.3.1. Factors Influencing Prices
- 3.4. Regulatory Framework
- 3.4.1. Standards & Compliances
- 3.5. Market Dynamics
- 3.5.1. Market Driver Analysis
- 3.5.2. Market Restraint Analysis
- 3.5.3. Market Challenges Analysis
- 3.5.4. Market Opportunity Analysis
- 3.6. Porter's Five Forces Analysis
- 3.6.1. Bargaining Power of Suppliers
- 3.6.2. Bargaining Power of Buyers
- 3.6.3. Threat of Substitution
- 3.6.4. Threat of New Entrants
- 3.6.5. Competitive Rivalry
- 3.7. PESTLE Analysis
- 3.7.1. Political
- 3.7.2. Economic
- 3.7.3. Social Landscape
- 3.7.4. Product
- 3.7.5. Environmental
- 3.7.6. Legal
Chapter 4. Quetiapine Intermediate Chemicals Market: Product Estimates & Trend Analysis
- 4.1. Quetiapine Intermediate Chemicals Market: Product Movement Analysis, 2024 & 2030
- 4.2. 1-[2-(2-Hydroxyethoxy) ethyl]Piperazine
- 4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.3. Dibenzo[b,f][1,4]thiazepin 11 (10 H)-one
- 4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 4.4. Other Products
- 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Quetiapine Intermediate Chemicals Market: End Use Estimates & Trend Analysis
- 5.1. Quetiapine Intermediate Chemicals Market: End Use Movement Analysis, 2024 & 2030
- 5.2. Pharmaceuticals
- 5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 5.3. Other End Uses
- 5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Quetiapine Intermediate Chemicals Market: Regional Estimates & Trend Analysis
- 6.1. Regional Analysis, 2024 & 2030
- 6.2. North America
- 6.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.2.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.2.4. U.S.
- 6.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.2.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.2.5. Canada
- 6.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.2.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.2.6. Mexico
- 6.2.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.2.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.2.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.3. Europe
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.3.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.3.4. Germany
- 6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.3.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.3.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.3.5. UK
- 6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.3.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.3.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.3.6. France
- 6.3.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.3.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.3.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.3.7. Italy
- 6.3.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.3.7.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.3.7.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.3.8. Spain
- 6.3.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.3.8.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.3.8.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.4.4. China
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.4.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.4.5. India
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.4.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.4.6. Japan
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.4.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.4.7. South Korea
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.4.7.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.4.7.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.5. Latin America
- 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.5.4. Brazil
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.5.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.5.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.5.5. Argentina
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.5.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.5.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.6. Middle East & Africa
- 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.6.4. Saudi Arabia
- 6.6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.6.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.6.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
- 6.6.5. South Africa
- 6.6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
- 6.6.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
- 6.6.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments by Key Market Participants
- 7.2. Company Categorization
- 7.3. Company Heat Map Analysis
- 7.4. Company Market Positioning Analysis, 2024
- 7.5. Strategy Mapping
- 7.6. Company Profiles/Listing
- 7.6.1. Merck KGaA
- 7.6.1.1. Company Overview
- 7.6.1.2. Financial Performance
- 7.6.1.3. Product Benchmarking
- 7.6.2. Shreeneel Chemicals
- 7.6.2.1. Company Overview
- 7.6.2.2. Financial Performance
- 7.6.2.3. Product Benchmarking
- 7.6.3. Emeron Electric Co.
- 7.6.3.1. Company Overview
- 7.6.3.2. Financial Performance
- 7.6.3.3. Product Benchmarking
- 7.6.4. Luye Pharma Group
- 7.6.4.1. Company Overview
- 7.6.4.2. Financial Performance
- 7.6.4.3. Product Benchmarking
- 7.6.5. Argana Group
- 7.6.5.1. Company Overview
- 7.6.5.2. Financial Performance
- 7.6.5.3. Product Benchmarking
- 7.6.6. IOL Chemicals & Pharmaceuticals Ltd
- 7.6.6.1. Company Overview
- 7.6.6.2. Financial Performance
- 7.6.6.3. Product Benchmarking
- 7.6.7. AR Lifesciences
- 7.6.7.1. Company Overview
- 7.6.7.2. Financial Performance
- 7.6.7.3. Product Benchmarking
- 7.6.8. ALLCHEM LIFESCIENCE PVT. LTD.
- 7.6.8.1. Company Overview
- 7.6.8.2. Financial Performance
- 7.6.8.3. Product Benchmarking
- 7.6.9. AstraZeneca
- 7.6.9.1. Company Overview
- 7.6.9.2. Financial Performance
- 7.6.9.3. Product Benchmarking
- 7.6.10. Shreeneel Chemicals
- 7.6.10.1. Company Overview
- 7.6.10.2. Financial Performance
- 7.6.10.3. Product Benchmarking
- 7.6.11. Aether Industries
- 7.6.11.1. Company Overview
- 7.6.11.2. Financial Performance
- 7.6.11.3. Product Benchmarking
- 7.6.1. Merck KGaA
